Medcann Industries, Inc.
NSRS
$0.00
$0.000.00%
OTC PK
| 01/31/2012 | 10/31/2011 | 07/31/2011 | 04/30/2011 | 01/31/2011 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 18,375.00% | 768.85% | 366.04% | 3,000.00% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18,375.00% | 768.85% | 366.04% | 4,666.67% | -- |
| Operating Income | -18,375.00% | -768.85% | -366.04% | -4,666.67% | -- |
| Income Before Tax | -33,550.00% | -831.15% | -377.36% | -5,783.33% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33,550.00% | -831.15% | -377.36% | -5,783.33% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33,550.00% | -831.15% | -377.36% | -5,783.33% | -- |
| EBIT | -18,375.00% | -768.85% | -366.04% | -4,666.67% | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -34,265.96% | -570.84% | -244.33% | -3,954.46% | -1,466.67% |
| Normalized Basic EPS | -34,710.34% | -571.71% | -244.23% | -3,961.90% | -- |
| EPS Diluted | -34,265.96% | -570.84% | -244.33% | -3,954.46% | -1,466.67% |
| Normalized Diluted EPS | -34,710.34% | -571.71% | -244.23% | -3,961.90% | -- |
| Average Basic Shares Outstanding | 6.66% | 39.20% | 38.88% | 36.12% | 18.33% |
| Average Diluted Shares Outstanding | 6.66% | 39.20% | 38.88% | 36.12% | 18.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |